Albert Bowers, 60; Head of Syntex Firm

Albert Bowers, prominent scien-
{ist and chairman and former chief
execulive officer of Syntex, the
Palo Alto-based pharmaceutical
company, has died, He was 60.

Bowers died Thursday night at
the UC San Francisco Medical
Center after an extended battle
With heart discase, the company
announced Friday.

Joining the company in 1956 as
research group Icader, Bowers
published more than 90 scientific
papers on steroid research and
originated more than 120 U.S. pat-
ents, Among his major accomplish-
ments were developing methods
for the selective fluorination of
steroids, which helped create topi-
eal ointments for treating skin

diseases, and developing a special
synthesis for norethindrone, which
permitted large-scale manufacture
of that oral contraceptive agent.

Bowers became president of
Syntex in 1976, was chief executive
officer from 1980 to 1989 and had
served as chairman of the board
since 1981. Because of poor health,
he had planned to retire July 31.

In 1964, Bowers received the
Science Prize from the Mexican
Academy of Science.

He had served as chairman of
the board of the Pharmaceutical
Manufacturers Assn., the indus-
try's national trade group.

Born in Manchester, England,
July 16, 1930, Bowers was graduat-
ed from London University with a

bachelor's degree in chemistry and
from the University of Manchester
with a doctorate in organic chem-
istry, He did postdoctoral work in
the United States on a Fulbright
Fellowship.

Bowers is survived by his wife,
Gwynn Akin Bowers, his mother,
five daughters, two brothers, a
sister and two grandsons.

The family has asked that any
memorial contributions be made to
the Foundation for Medicine,
which funds research on heart
disease, in care of Dr. Kanu Chat-
terjee, UC San Francisco, 505 Par-
nassus, Room 1186 of Moffitt
Building, San Francisco, Calif.
94143.
